PUBLICATIONS FDA Decisions Expected: May 2025 Your monthly synopsis of new drugs expected to hit the market April 14, 2025 Drug pipeline for May 2025 At Prime Therapeutics (Prime), we have...

PUBLICATIONS FDA Decisions Expected: February 2025 Drug pipeline for February 2025 January 15, 2025 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we...

Event features discussions about health care industry trends, best practices and innovations

publications High-Cost Therapy Profile: May 2025 Vusolimogene oderparepvec Intratumoral | Replimune Oncology-Gene therapy May 15, 2025 Proposed indications Advanced melanoma FDA approval...

Reimagine your pharmacy benefit partner Designed by health plans for health plans, we provide an innovative pharmacy benefit manager (PBM) partnership experience. Breadcrumb Home Who we are About...

publications Drug Approvals: January 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches January 31, 2025 Specialty New drugs Dec....

Drug Approvals Monthly Update: August 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

publications Drug Approvals: December 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches December 30, 2024 Specialty New drugs...

research 10 research posters presented by Prime at AMCP Nexus 2024 Studies include Prime’s GLP-1 obesity research, health equity, and real world case studies October 18, 2024 Evaluating the...

Drug Approvals Quarterly Update: January 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process....

Help your members take their health to the next level KeepWell™ offers a personalized and effective path to wellness, supporting members with obesity, diabetes, hypertension and high cholesterol....

Discover next-gen pharmacy solutions We deliver innovative pharmacy benefit management and a differentiated experience that puts customer and member needs first Breadcrumb Home Who we are About us...

publications High-Cost Therapy Profile: April 2025 Deramiocel Intravenous (IV) | Nippon Shinyaku Co., Ltd./Capricor Therapeutics, Inc. Cardiovascular/Musculoskeletal April 15, 2025 Proposed...

This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process.

This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process.

Drug Approvals Quarterly Update: July 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process. Prime...

Drug Approvals September 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and...

Event features Prime experts

2024 AMCP Annual Posters As presented at the 2024 Academy of Managed Care Pharmacy (AMCP) Annual Meeting. Click on the poster image to view the full-size version. Save: Making medications more...

Help your members on high-cost clinical drugs Our deep expertise and holistic view of patient care help you manage the most complex conditions and expensive specialty drugs across both pharmacy...